Back to UBS Group AG UBS Group AG

HOWLHOWL
Showing 8 of 21 quarters

Position history for UBS Group AGUBS Group AG's holdings in WEREWOLF THERAPEUTICS INC

UBS Group AG holds 215,838 shares of HOWL (WEREWOLF THERAPEUTICS INC), worth $77,702 as of 2026-Q2. The position was increased (+222.8% shares).

Current Value

$77,702

Current Shares

215,838

Total Value Change

+$44,887

Total Shares Change

+200,359

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
215,838
+222.8%
$77,7020.0%$0.36
23
2026-Q1
Increased
66,857
+10.1%
$55,6920.0%$0.59
16
2025-Q4
Increased
60,708
+375.2%
$38,4280.0%$0.61
22
2025-Q3
Increased
12,776
+271.6%
$25,1690.0%$2.19
21
2025-Q2
Decreased
3,438
-80.6%
$3,7470.0%$1.02
0
2025-Q1
Decreased
17,688
-42.0%
$17,1930.0%$1.03
0
2024-Q4
Increased
30,493
+97.0%
$45,1300.0%$1.48
22
2024-Q3
Increased
15,479
+57.8%
$32,8150.0%$2.12
19

Other major holders of HOWL: RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used